EUVIMEDEUVIMED entdecken
Crossref

Multi-omics analyses of choroid plexus carcinoma cell lines reveal potential targetable pathways and alterations

Dina Hesham, Jotaro On, Nouran Alshahaby, Nada Amer, Sameh Magdeldin, Masayasu Okada, Yoshihiro Tsukamoto, Tetsuya Hiraishi, Chihaya Imai, Shujiro Okuda, Toshifumi Wakai, Akiyoshi Kakita und 3 weitere

Journal of Neuro-Oncology · 2024

DOI: 10.1007/s11060-023-04484-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2024. Verfasst von Dina Hesham und 14 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Biology Research Program, Basic Research Unit, Research Department, Children's Cancer Hospital Egypt 57357, 1 Sekket El Emam, El Madbah El Kade…. Hauptthemen laut MEDLINE: Multiomics, Choroid Plexus Neoplasms, Carcinoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Niigata Prefectural Bureau of Hospital Administration Grant, Egypt Cancer Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Choroid plexus carcinomas (CPCs) are extremely rare brain tumors and carry a dismal prognosis. Treatment options are limited and there is an urgent need to develop models to further research. In the present study, we established two CPC cell lines and performed multi-omics analyses. These cell lines serve as valuable models to propose new treatments in these rare but deadly brain tumors. METHODS: Multi-omic profiling including, (i) methylation array (EPIC 850 K), (ii) whole genome sequencing (WGS), (iii) CANCERPLEX cancer genome panel testing, (iv) RNA sequencing (RNA-seq), and (v) proteomics analyses were performed in CCHE-45 and NGT131 cell lines. RESULTS: Both cell lines were classified as methylation class B. Both harbored pathogenic TP53 point mutations; CCHE-45 additionally displayed TP53 loss. Furthermore, alterations of the NOTCH and WNT pathways were also detected in both cell lines. Two protein-coding gene fusions, BZW2-URGCP, and CTTNBP2-ERBB4, mutations of two oncodrivers, GBP-4 and KRTAP-12-2, and several copy number alterations were observed in CCHE-45, but not NGT131. Transcriptome and proteome analysis identified shared and unique signatures, suggesting that variability in choroid plexus carcinoma tumors may exist. The discovered difference's importance and implications highlight the possible diversity of choroid plexus carcinoma and call for additional research to fully understand disease pathogenesis. CONCLUSION: Multi-omics analyses revealed that the two choroid plexus carcinoma cell lines shared TP53 mutations and other common pathway alterations and activation of NOTCH and WNT pathways. Noticeable differences were also observed. These cell lines can serve as valuable models to propose new treatments in these rare but deadly brain tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MultiomicsChoroid Plexus NeoplasmsCarcinomaHumansTumor Suppressor Protein p53Cell LineChoroid PlexusDNA-Binding Proteins

Stichwörter der Autor:innen

Cell lineChoroid plexus carcinomaChoroid plexus tumorsMulti-omics analyses

Substanzen

Tumor Suppressor Protein p53BZW2 protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Tumor Biology Research Program, Basic Research Unit, Research Department, Children's Cancer Hospital Egypt 57357, 1 Sekket El Emam, El Madbah El Kadeem Yard, Sayeda Zeinab, Cairo, Egypt.
  • Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, 951-8585, Japan.
  • Proteomics and Metabolomics Research Program, Basic Research Unit, Research Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt.
  • Department of Physiology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.
  • Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, 951-8510, Japan.
  • Division of Bioinformatics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, 951-8514, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Niigata Prefectural Bureau of Hospital Administration Grant
  • Egypt Cancer Network

Zitieren

APA

Hesham, D., On, J., Alshahaby, N., Amer, N., Magdeldin, S., Okada, M., Tsukamoto, Y., Hiraishi, T., Imai, C., Okuda, S., Wakai, T., Kakita, A., Oishi, M., El-Naggar, S., & Natsumeda, M. (2024). Multi-omics analyses of choroid plexus carcinoma cell lines reveal potential targetable pathways and alterations. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-023-04484-3

Vancouver

Hesham D, On J, Alshahaby N, Amer N, Magdeldin S, Okada M, et al. Multi-omics analyses of choroid plexus carcinoma cell lines reveal potential targetable pathways and alterations. Journal of Neuro-Oncology. 2024. doi:10.1007/s11060-023-04484-3

BibTeX
@article{Hesham2024,
  author = {Hesham, Dina and On, Jotaro and Alshahaby, Nouran and Amer, Nada and Magdeldin, Sameh and Okada, Masayasu and Tsukamoto, Yoshihiro and Hiraishi, Tetsuya and Imai, Chihaya and Okuda, Shujiro and Wakai, Toshifumi and Kakita, Akiyoshi and Oishi, Makoto and El-Naggar, Shahenda and Natsumeda, Manabu},
  title = {Multi-omics analyses of choroid plexus carcinoma cell lines reveal potential targetable pathways and alterations},
  journal = {Journal of Neuro-Oncology},
  year = {2024},
  doi = {10.1007/s11060-023-04484-3}
}
Kostenlos starten →